by Leanne Talbot | Mar 5, 2019
Read our monthly roundup. February 2019. [npfButton size=“small” text=”Click here to read our February roundup” href=”https://www.neuroendocrinecancer.org.uk/wp-content/uploads/NPF-February-19-Roundup.pdf”... by Leanne Talbot | Feb 28, 2019
In the UK almost half of those diagnosed with cancer will be told they have a rare or uncommon type of cancer. It can be more difficult to find information about rare or uncommon cancers. And it might be difficult to find other people who have the same type of cancer... by Leanne Talbot | Feb 22, 2019
Delivery of high-quality care that produces better outcomes for patients needs a high-quality workforce: skilled and competent practitioners who are fit to deliver care in the future health and social care system. A competency framework is founded on nursing... by Leanne Talbot | Feb 13, 2019
By 2030 four million people in the UK will be living with the long-term consequences of cancer, but currently there is very little research on the problems they face and how these can be tackled. To help them live better lives, more focused research is needed. To... by Leanne Talbot | Feb 13, 2019
“A fabulous account of Mark’s venture into the new patient involvement panel for NICE. Really worth a read and I am totally behind talking about the Chair’s role in an appraisal meeting. It is a daunting experience without the Chair dismissing your comments, and... by Leanne Talbot | Feb 12, 2019
European Reference Networks (ERNs) are virtual networks involving healthcare providers across Europe. They aim to tackle complex or rare diseases and conditions that require highly specialised treatment and concentrated knowledge and... 